| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 7, 2022Virtual Press Office and PR Newswire: General Trade show news
Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced that company leadership is scheduled to present at the 21st Annual...
-
Apr 7, 2022Virtual Press Office and PR Newswire: General Trade show news
CURE®, the industry-leading multimedia platform providing cancer updates, research, and education is proud to announce the finalists for the 2022 Extraordinary Healer® award for oncology...
-
Apr 7, 2022Virtual Press Office and PR Newswire: General Trade show news
Sickle Cell Patients Treated With Endari® had Statistically Significantly Fewer Vaso-Occlusive Events and Hospitalizations Through 72 Weeks Follow-up, Versus Baseline Adverse Events Among These...
-
Apr 7, 2022Virtual Press Office and PR Newswire: General Trade show news
Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its chief...
-
Apr 7, 2022Virtual Press Office and PR Newswire: General Trade show news
Poster Presentations to highlight the latest research on OBI-3424 (AKR1C3 small molecule pro-drug) and emerging Globo H science. TAIPEI, Taiwan, April 7, 2022 /PRNewswire/ -- OBI Pharma, Inc....
